The author presents a case in which the Artix Thrombectomy System (Inari Medical) was utilized in a hybrid procedure to revascularize a thrombosed axillary-profunda bypass graft followed by profundoplasty.
The author presents a case in which the Artix Thrombectomy System (Inari Medical) was utilized in a hybrid procedure to revascularize a thrombosed axillary-profunda bypass graft followed by profundoplasty.
The Serranator® combines balloon angioplasty with embedded serration elements designed to create multiple longitudinal lines of interrupted scoring along the arterial wall.
The Serranator® combines balloon angioplasty with embedded serration elements designed to create multiple longitudinal lines of interrupted scoring along the arterial wall.
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
The operations of an ASC (vs. hospital setting) often benefit from more efficient workflows, fewer delays, and shorter patient stays, thus leading to higher patient satisfaction and often increased volumes over time.(1)
The operations of an ASC (vs. hospital setting) often benefit from more efficient workflows, fewer delays, and shorter patient stays, thus leading to higher patient satisfaction and often increased volumes over time.(1)
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Ivana Kumar; Anshita Kumari, MBBS; Kusum Lata, MD, FACC, FSCAI
Peripheral vascular disease (PVD), specifically in its more advanced forms such as chronic limb-threatening ischemia (CLTI), presents a great clinical challenge. Endovascular interventions have become the primary approach for...
Peripheral vascular disease (PVD), specifically in its more advanced forms such as chronic limb-threatening ischemia (CLTI), presents a great clinical challenge. Endovascular interventions have become the primary approach for...
"My concern about embolization during interventional procedures dates back almost 3 decades," says Dr. Bates. "While researching and developing one of the early carotid filter systems and as a co-inventor of carotid flow reversal, it became...
"My concern about embolization during interventional procedures dates back almost 3 decades," says Dr. Bates. "While researching and developing one of the early carotid filter systems and as a co-inventor of carotid flow reversal, it became...
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
"My concern about embolization during interventional procedures dates back almost 3 decades," says Dr. Bates. "While researching and developing one of the early carotid filter systems and as a co-inventor of carotid flow reversal, it became...
"My concern about embolization during interventional procedures dates back almost 3 decades," says Dr. Bates. "While researching and developing one of the early carotid filter systems and as a co-inventor of carotid flow reversal, it became...
"The DETOUR System (Endologix) and percutaneous transmural arterial bypass (PTAB) represents a truly exciting addition to our armamentarium for the treatment of complex peripheral artery disease (PAD) patients," says Jaafar A. Golzar, MD,...
"The DETOUR System (Endologix) and percutaneous transmural arterial bypass (PTAB) represents a truly exciting addition to our armamentarium for the treatment of complex peripheral artery disease (PAD) patients," says Jaafar A. Golzar, MD,...
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
At ISET 2025, Anvar Babaev, MD, PhD, presented findings from the Disrupt PAD BTK II study, a prospective, multicenter trial assessing the efficacy and safety of Shockwave IVL in treating calcified below-the-knee PAD.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
The right clinical endpoint for assessing patency was discussed on Wednesday afternoon in a VIVA@LINC session by Raghu Kolluri, MD, System Medical Director at OhioHealth and President of Syntropic Core Lab in Ohio.
With a collaborative culture, high-volume expertise, and investment in cutting edge technology, Baystate Medical Center has become a nationally recognized leader in cardiovascular care. In the recent renovation and expansion of Baystate’s...
With a collaborative culture, high-volume expertise, and investment in cutting edge technology, Baystate Medical Center has become a nationally recognized leader in cardiovascular care. In the recent renovation and expansion of Baystate’s...
Market tends are showing that more procedures are moving to out-of-hospital care settings, such as ambulatory surgery centers (ASCs) and office-based labs (OBLs) due to financial and operational benefits to the healthcare system and desire to...
Market tends are showing that more procedures are moving to out-of-hospital care settings, such as ambulatory surgery centers (ASCs) and office-based labs (OBLs) due to financial and operational benefits to the healthcare system and desire to...
Manit Sabharwal ; Morton J. Kern, MD, MSCAI, FACC, FAHA; Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI
Long-term radialists Morton Kern, MD, and Arnold Seto, MD, MPA, discuss a novel radial access tool, the Prelude Wave™, with Merit Medical®’s Manit Sabharwal. Discussion ranges from transradial access clinical tips to the challenges of...
Long-term radialists Morton Kern, MD, and Arnold Seto, MD, MPA, discuss a novel radial access tool, the Prelude Wave™, with Merit Medical®’s Manit Sabharwal. Discussion ranges from transradial access clinical tips to the challenges of...
In this video, Ryan K. Kaple, MD, FACC, FSCAI, discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
In this video, Ryan K. Kaple, MD, FACC, FSCAI, discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
Bailey Ann Richardson, NP-C, RNFA, CNOR, RCIS; Morton J. Kern, MD, MSCAI, FACC, FAHA; Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI
A discussion of the study presented at SCAI's 2025 Annual Meeting, " Percutaneous Coronary Intervention in Ambulatory Surgery Centers: Procedural Volume Trends and Outcomes in the Medicare Population".
A discussion of the study presented at SCAI's 2025 Annual Meeting, " Percutaneous Coronary Intervention in Ambulatory Surgery Centers: Procedural Volume Trends and Outcomes in the Medicare Population".
"The signal has been important and clinically meaningful," says Behnam Tehrani, MD. "At the 90-day visit, we have seen a median blood pressure reduction of over 30 mmHg systolic and 10 mmHg diastolic, with a median reduction of 1.3...
"The signal has been important and clinically meaningful," says Behnam Tehrani, MD. "At the 90-day visit, we have seen a median blood pressure reduction of over 30 mmHg systolic and 10 mmHg diastolic, with a median reduction of 1.3...
Bailey Ann Estes, AGNP-C, MSN, RN-BC, RCIS, RNFA; Morton J. Kern, MD, MSCAI, FACC, FAHA; Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI
Join Bailey Ann Richardson, NP-C, RNFA, CNOR, RCIS, and Drs Morton Kern and Arnold Seto, in a SCAI 2025 discussion that highlights four trials across the interventional cardiology spectrum.
Join Bailey Ann Richardson, NP-C, RNFA, CNOR, RCIS, and Drs Morton Kern and Arnold Seto, in a SCAI 2025 discussion that highlights four trials across the interventional cardiology spectrum.
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
The author presents a case in which the Artix Thrombectomy System (Inari Medical) was utilized in a hybrid procedure to revascularize a thrombosed axillary-profunda bypass graft followed by profundoplasty.
The author presents a case in which the Artix Thrombectomy System (Inari Medical) was utilized in a hybrid procedure to revascularize a thrombosed axillary-profunda bypass graft followed by profundoplasty.
The Serranator® combines balloon angioplasty with embedded serration elements designed to create multiple longitudinal lines of interrupted scoring along the arterial wall.
The Serranator® combines balloon angioplasty with embedded serration elements designed to create multiple longitudinal lines of interrupted scoring along the arterial wall.
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Eric Secemsky, MD, discusses his AMP 2025 presentation entitled “Outcomes in Patients With and Without CLTI: A Systematic Literature Review on Atherectomy for Peripheral Interventions”.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
"PAD too often goes unnoticed until it reaches a critical stage," said Srihari S. Naidu, MD, MSCAI, "Many patients only learn they have PAD when pain prevents them from walking, when wounds no longer heal, or when they are facing the...
The operations of an ASC (vs. hospital setting) often benefit from more efficient workflows, fewer delays, and shorter patient stays, thus leading to higher patient satisfaction and often increased volumes over time.(1)
The operations of an ASC (vs. hospital setting) often benefit from more efficient workflows, fewer delays, and shorter patient stays, thus leading to higher patient satisfaction and often increased volumes over time.(1)
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Designed to treat blocked arteries below the knee (BTK), the Esprit BTK System dissolves over time after restoring blood flow, offering the possibility of better outcomes for people with the most severe form of PAD.
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Vascular surgeon Dr. Takahiro Tokuda, from Nagoya Heart Center in Japan, outlines new evidence comparing 2 contemporary revascularization options for heavily calcified femoropopliteal lesions
Ivana Kumar; Anshita Kumari, MBBS; Kusum Lata, MD, FACC, FSCAI
Peripheral vascular disease (PVD), specifically in its more advanced forms such as chronic limb-threatening ischemia (CLTI), presents a great clinical challenge. Endovascular interventions have become the primary approach for...
Peripheral vascular disease (PVD), specifically in its more advanced forms such as chronic limb-threatening ischemia (CLTI), presents a great clinical challenge. Endovascular interventions have become the primary approach for...
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular
BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular
BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
The SAPIEN M3 transcatheter mitral valve replacement (TMVR) system is indicated for the treatment of symptomatic moderate-to-severe or severe MR in patients who are deemed unsuitable for surgery or transcatheter edge-to-edge repair (TEER)...
The SAPIEN M3 transcatheter mitral valve replacement (TMVR) system is indicated for the treatment of symptomatic moderate-to-severe or severe MR in patients who are deemed unsuitable for surgery or transcatheter edge-to-edge repair (TEER)...
MIDWAY 43 and MIDWAY 62 delivery catheters are designed to provide ideal tracking and a stable platform to support the delivery of various embolisation therapies in the neurovasculature.
MIDWAY 43 and MIDWAY 62 delivery catheters are designed to provide ideal tracking and a stable platform to support the delivery of various embolisation therapies in the neurovasculature.
Both the ACC and AHA scientific statements support the use of quantitative coronary plaque analysis to identify high-risk patients, enabling the immediate and appropriate initiation of preventive treatment.
Both the ACC and AHA scientific statements support the use of quantitative coronary plaque analysis to identify high-risk patients, enabling the immediate and appropriate initiation of preventive treatment.
The new guideline includes additions related to the role of clinicians with specialized expertise in guiding the care of adults with congenital heart disease; updates regarding mental health, physical activity, pregnancy and heart failure;...
The new guideline includes additions related to the role of clinicians with specialized expertise in guiding the care of adults with congenital heart disease; updates regarding mental health, physical activity, pregnancy and heart failure;...
When people with prediabetes bring their blood glucose back into the normal range through lifestyle changes, their risk of heart attack, heart failure, and premature death is cut in half.
When people with prediabetes bring their blood glucose back into the normal range through lifestyle changes, their risk of heart attack, heart failure, and premature death is cut in half.
The research suggests that CAVT, a technology designed to rapidly remove blood clots via microprocessor-controlled aspiration, has the potential to help reduce healthcare costs.
The research suggests that CAVT, a technology designed to rapidly remove blood clots via microprocessor-controlled aspiration, has the potential to help reduce healthcare costs.
